Buspirone Hydrochloride Tablet
Product Images NDC 50090-7785

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 50090-7785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)
Buspirone Hydrochloride 10 mg oral tablet film scored with '0' on one side and '9' on the other side, showing the pill's imprint for identification.*
FDA Label Image

15 mg (the Entire Tablet) (15mg 15mg)

15 mg (the Entire Tablet) (15mg 15mg)
The image shows a portion of a medication tablet imprinted with the numeric code '093'. The tablet surface is white or light-colored, and the imprint is segmented into two parts separated by a score line.*
FDA Label Image

5 mg (one Third Of A Tablet) (15mg 5mg)

FDA Label Image

7.5 Xxx (15mg 7 5)

7.5 Xxx (15mg 7 5)
Buspirone Hydrochloride 10 mg oral tablet showing one side marked with the score line and the imprint '0'. The tablet is round and white, consistent with the generic formulation by A-S Medication Solutions.*
FDA Label Image

10 mg (one Third Of A Tablet) (30mg 10mg)

10 mg (one Third Of A Tablet) (30mg 10mg)
Buspirone Hydrochloride 10 mg oral tablet with the number '10' imprinted on one side in black on a white, square-shaped tablet. The image shows the tablet's size and imprint detail but no other markings or packaging elements.*
FDA Label Image

15 mg Entire Tablet (30mg 15mg)

15 mg Entire Tablet (30mg 15mg)
Buspirone Hydrochloride 10 mg oral tablet. The image shows a close-up of the tablet imprint with the number '10' clearly visible, indicating the strength of 10 mg. The tablet is white and round, consistent with the product from A-S Medication Solutions.*
FDA Label Image

20 mg (two Thirds Of A Tablet) (30mg 20mg)

20 mg (two Thirds Of A Tablet) (30mg 20mg)
The image shows a blister pack containing two tablets of Buspirone Hydrochloride 10 mg. Each tablet is rectangular with rounded edges and is scored or separated into two sections, each marked with the number 10. The tablets are intended for oral administration and labeled by A-S Medication Solutions.*
FDA Label Image

30 mg (the Entire Tablet) (30mg 30mg)

30 mg (the Entire Tablet) (30mg 30mg)
Buspirone Hydrochloride 10 mg oral tablet imprinted with '10 10 10' in black on a white, capsule-shaped tablet. No packaging or labeler information visible in the image.*
FDA Label Image

Break In Half (Break)

Break In Half (Break)
An instructional line drawing showing two hands holding a tablet between the fingers, demonstrating how to split or break the tablet.*
FDA Label Image

Label Image (Lbl500907785)

Label Image (Lbl500907785)
Buspirone Hydrochloride 10 mg oral tablets packaging label from A-S Medication Solutions. The label includes the drug name, strength (10 mg), dosage form (tablet), quantity (90 tablets), and storage instructions (store at 68 to 77 degrees Fahrenheit). It also displays the labeler name and product NDC (50090-7785).*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of buspirone hydrochloride showing the arrangement of heterocyclic rings and functional groups including a cyclopropyl-piperazine moiety linked to a pyrimidinyl group and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.